Ovarian Cancer Second Edition /

Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined, due to a continued inability to achieve detection of early (rather than advanced) stage disease and the lack of effective tumor-specific therapeutics. Ovarian carcinogenesis, invasion, and...

Full description

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Stack, M. Sharon. (Editor), Fishman, David A. (Editor)
Format: Electronic
Language:English
Published: Boston, MA : Springer US, 2010.
Edition:2.
Series:Cancer Treatment and Research, 149
Subjects:
Online Access:https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-0-387-98094-2
Table of Contents:
  • Chemoprevention of Ovarian Cancer
  • Staging and Surgical Treatment
  • Novel Therapeutic Targets
  • Biomarker Targets and Novel Therapeutics
  • Tumor Suppressor Genes
  • Epigenetics and Ovarian Cancer
  • Aberrant Epithelial Differentiation in Ovarian Cancer
  • The Human Kallikrein Gene Family
  • Soluble Epidermal Growth Factor Receptor (sEGFR)
  • Activated Epidermal Growth Factor Receptor in Ovarian Cancer
  • Ras-Superfamily GTP-ases in Ovarian Cancer
  • Lipid Generation and Signaling in Ovarian Cancer
  • LPA and Invasion
  • Cell Adhesion in Ovarian Cancer
  • Microenvironmental Regulation of Ovarian Cancer Metastasis
  • Organotypic Models of Metastasis
  • Animal Models of Ovarian Cancer
  • Index.